Key Takeaways
- Doctors Without Borders (MSF) called on governments and funders to better equip communities to prevent, detect, and respond to drug-resistant infections before, during, and after acute crises.
- An estimated two billion people live in conflict-affected settings. In 2025, forced displacement affected an unprecedented 122 million people.
- MSF's four requests are to invest before crises, plan for crises with affected communities, protect health care, and count everyone in surveillance and research.
- MSF addresses AMR in more than 20 countries through over 50 projects.
- The Ministerial Conference in Abuja (6–8 December 2026) is a key opportunity for concrete government commitments and for the launch of the Independent Panel for Evidence for Action against AMR.
Four requests from MSF at the AMR multi-stakeholder partnership platform
In particular, at the Fourth Plenary Assembly of the AMR Multi-Stakeholder Partnership Platform held in Rome, Italy, this week, Doctors Without Borders (MSF) asked governments and funders to:
- Invest before crises to fund national AMR plans that strengthen infection prevention and control (IPC), water, sanitation and hygiene (WASH), stewardship and laboratories
- Plan for crises along with affected communities to build AMR into emergency preparedness and adapt national AMR plans in protracted crises, implementing context-specific interventions
- Protect health care to uphold international humanitarian law
- Count everyone to include conflict settings in surveillance and research, and ensure equitable access to antimicrobials and diagnostics
Doctors Without Borders (MSF) deputy to the International Medical Secretary on what is at stake for patients
Dr Cecilia Ferreyra, infectious diseases specialist and Deputy to the International Medical Secretary of MSF, speaking on the stakes for patients and the funding MSF is asking governments and donors to provide:
“For the people we treat, antimicrobial resistance is not a 2050 projection. It is a newborn with sepsis, or a person with a war wound, whose infection no longer responds to the antibiotics we have.”
“The global fight against antimicrobial resistance will fail if it leaves people living through conflict and displacement. We are asking governments and donors for dedicated funding and adapted national AMR plans that include people vulnerable to crises from the start. The commitments made here and in the Ministerial Conference in Abuja next month will help decide whether these patients still have medical tools that work.”
Why conflict and humanitarian crises intensify the risks of antimicrobial resistance
The risks and consequences of AMR are especially acute in settings affected by conflict and humanitarian crises, where inadequate WASH measures, poor infection prevention and control, and limited access to microbiology, diagnostic capacity, and appropriate antimicrobials contribute to the emergence and spread of drug-resistant infections. Destruction of healthcare facilities and infrastructure for water and sanitation, shortages of healthcare workers, disrupted supply chains, and overcrowded living conditions further compound the AMR crisis.
How MSF addresses AMR in more than 20 countries
MSF addresses AMR in more than 20 countries through over 50 projects, focusing on infection prevention and control, antibiotic stewardship, microbiology-based diagnostics, and surveillance. Our teams see the diversity of ways in which crises subject people to risk for and from AMR. From treating patients with severe wounds and drug-resistant infections to caring for malnourished children and newborns with sepsis, and people living with HIV who develop opportunistic infections, MSF works to strengthen healthcare workers’ capacity to counter AMR through provision of quality, people-centered care.
Antimicrobial Resistance on the ground: Gaza, South Sudan, Ethiopia and Nigeria
Dr Rupa Kanapathipillai, Antimicrobial Stewardship Lead, MSF Operational Centre Paris, speaking on how AMR is a consequence of conflict, displacement and fragile health systems, with examples from MSF’s work:
“Antimicrobial resistance is increasingly becoming a consequence of conflict, displacement and fragile health systems,”
“In Gaza, facilities designed for 250–300 patients a day received as many as 700, with wound care provided from shared trolleys. In South Sudan, Ethiopia and Nigeria, where displacement, flooding and outbreaks hit already stretched clinics, premature babies with sepsis and severely malnourished children are being treated where our antibiograms show high resistance, even in remote areas. Resistance follows displacement and weak health systems, not just the front line.”
Global AMR opportunities: The global action plan and the Abuja Ministerial Conference
Global initiatives, including the updated Global Action Plan on AMR (adopted in May 2026), the planned launch of the Independent Panel for Evidence for Action against AMR, at the 5th Global High-Level Ministerial Conference on AMR in Abuja, Nigeria (6–8 December 2026), offer important opportunities to accelerate action. These initiatives are particularly crucial in light of recent shocks to global health and humanitarian financing that are taking us backwards rather than ahead.
What MSF wants from governments and the independent panel
Pauline Londeix, Advocacy Advisor, MSF Access, speaking on the commitments governments should make at the upcoming Ministerial Conference in Nigeria and the role of the Independent Panel:
“At the upcoming Ministerial Conference in Nigeria, governments must make concrete commitments and ensure that the Independent Panel on Evidence for Action against AMR will close critical evidence gaps in conflict-affected and humanitarian settings and translate evidence into action.”
“Meaningful representation of humanitarian actors, affected communities and low-income countries is also essential to guarantee the Panel’s work responds to the needs of people most at risk.”